Case Study: Henry Ford Health streamlines hereditary cancer, cystic fibrosis, and pharmacogenetics testing with SOPHiA GENETICS' exome solution

Henry Ford Health streamlines three assays into one exome-based solution with SOPHiA GENETICS

Henry Ford Health sought to enhance its genetic testing capabilities but was using multiple separate assays for different applications, creating a complex workflow. They partnered with SOPHiA GENETICS to find a more streamlined and comprehensive solution.

SOPHiA GENETICS implemented its SOPHiA DDM™ Exome Solution v3, which consolidated the separate workflows for hereditary cancer, cystic fibrosis, and pharmacogenetics into a single, powerful assay. This solution from SOPHiA GENETICS enabled the detection of SNVs, Indels, and CNVs in one comprehensive process, simplifying the health system's germline testing and offering broad gene coverage with a compact assay footprint.

Henry Ford Health